Ramtin Agah - Mar 15, 2023 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Shaun Bagai, by power of attorney
Stock symbol
RNXT
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
4
Date filed
3/29/2023, 04:57 PM
Previous filing
Jun 9, 2022
Next filing
Jan 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Employee Stock Option (right to buy) Award $0 +65K $0.00 65K Mar 15, 2023 Common Stock 65K $3.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in 48 equal monthly installments beginning on January 1, 2023.